(Q47435099)

16 January 2018

title

Comparison of different routes of vaccination for eliciting antibody responses in the human stomach (English)

1 reference

16 January 2018

1 reference

5

Ann-Mari Svennerholm

1 reference

16 January 2018

Eva-Liz Johansson

1

1 reference

16 January 2018

Charlotta Bergquist

series ordinal

2

1 reference

16 January 2018

Anders Edebo

series ordinal

3

1 reference

16 January 2018

Camilla Johansson

series ordinal

4

1 reference

16 January 2018

language of work or name

English

0 references

publication date

1 February 2004

1 reference

16 January 2018

published in

Vaccine

1 reference

16 January 2018

volume

22

1 reference

16 January 2018

issue

8

1 reference

16 January 2018

page(s)

984-990

1 reference

16 January 2018

Geographical Pathology ofHelicobacter pyloriInfection: Is There More than One Gastritis?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.002

Helicobacter pylori infection and gastric lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.002

Pathophysiology of Helicobacter pylori-induced gastritis and peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.002

Helicobacter pylori infections in IgA deficiency: lack of role for the secretory immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.002

Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.002

Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.002

Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.002

Protection by human milk IgA against Helicobacter pylori infection in infancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.002

Actions of cholera toxin and the prevention and treatment of cholera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.002

Induction of B cell responses in the stomach of Helicobacter pylori- infected subjects after oral cholera vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.002

Human gastric B cell responses can be induced by intestinal immunisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.002

Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.002

Development of a new method for the determination of immune responses in the human stomach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.002

Lymphoid follicles in antral mucosa: immune response to Campylobacter pylori?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.002

Intestinal antibody responses after immunisation with cholera B subunit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.002

Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.002

Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.002

7 January 2021

Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.002

7 January 2021

Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.002

7 January 2021

Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.002

7 January 2021

Normal histology of the stomach

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.002

7 January 2021

10.1016/J.VACCINE.2003.09.002

Identifiers

DOI

1 reference

16 January 2018

1 reference

16 January 2018